title: Stage of disease at time of attendance of patients with colorectal cancer at the Department of Surgery of the General Hospital of Edessa.
abstract: It is acceptable that the stage of disease at time of attendance of patients with colorectal cancer (CRC) is the defining factor for patients' survival rate. From 1986 until 1998, 417 patients were treated in the Department of Surgery of the General Hospital of Edessa with CRC. For diagnosis, established endoscopic procedures were followed. CT, USG, MRI and histology were performed for staging. 85.4% of the patients had stage II, III and IV TNM/UICC tumour at the time of attendance.
authors.affiliation: Department of Surgery, General Hospital of Edessa, Greece. aeconomou@yahoo.gr
authors.forename: A
authors.initials: A
authors.lastname: Economou
authors.forename: K
authors.initials: K
authors.lastname: Saliangas
authors.forename: N
authors.initials: N
authors.lastname: Nikoloudis
authors.forename: E
authors.initials: E
authors.lastname: Andreadis
authors.forename: S
authors.initials: S
authors.lastname: Siminou
authors.forename: Z
authors.initials: Z
authors.lastname: Zacharopoulos
authors.forename: E
authors.initials: E
authors.lastname: Politidou
authors.forename: T
authors.initials: T
authors.lastname: Chrissidis
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001707:Biopsy, Needle; D015331:Cohort Studies; D003082:Colectomy / Q000379:methods / Q000401:mortality; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000401:mortality* / Q000473:pathology* / Q000601:surgery; D018450:Disease Progression; D018572:Disease-Free Survival; D042241:Early Diagnosis; D005260:Female; D006115:Greece; D006769:Hospitals, General; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009873:Operating Rooms; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012737:Sex Factors; D016019:Survival Analysis; D016896:Treatment Outcome